DK3187586T3 - Inducerbar co-ekspressionssystem - Google Patents

Inducerbar co-ekspressionssystem

Info

Publication number
DK3187586T3
DK3187586T3 DK16201998.8T DK16201998T DK3187586T3 DK 3187586 T3 DK3187586 T3 DK 3187586T3 DK 16201998 T DK16201998 T DK 16201998T DK 3187586 T3 DK3187586 T3 DK 3187586T3
Authority
DK
Denmark
Prior art keywords
inducerable
expression system
expression
Prior art date
Application number
DK16201998.8T
Other languages
Danish (da)
English (en)
Inventor
Sean Mcclain
Mark Valasek
Original Assignee
Absci Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Absci Llc filed Critical Absci Llc
Application granted granted Critical
Publication of DK3187586T3 publication Critical patent/DK3187586T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0051—Oxidoreductases (1.) acting on a sulfur group of donors (1.8)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y108/00—Oxidoreductases acting on sulfur groups as donors (1.8)
    • C12Y108/01—Oxidoreductases acting on sulfur groups as donors (1.8) with NAD+ or NADP+ as acceptor (1.8.1)
    • C12Y108/01007—Glutathione-disulfide reductase (1.8.1.7), i.e. glutathione reductase (NADPH)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y503/00—Intramolecular oxidoreductases (5.3)
    • C12Y503/04—Intramolecular oxidoreductases (5.3) transposing S-S bonds (5.3.4)
    • C12Y503/04001—Protein disulfide-isomerase (5.3.4.1), i.e. disufide bond-forming enzyme
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y603/00—Ligases forming carbon-nitrogen bonds (6.3)
    • C12Y603/02—Acid—amino-acid ligases (peptide synthases)(6.3.2)
    • C12Y603/02003—Glutathione synthase (6.3.2.3)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Slot Machines And Peripheral Devices (AREA)
  • Circuit Arrangement For Electric Light Sources In General (AREA)
  • Two-Way Televisions, Distribution Of Moving Picture Or The Like (AREA)
DK16201998.8T 2012-08-05 2013-08-05 Inducerbar co-ekspressionssystem DK3187586T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261679751P 2012-08-05 2012-08-05
US201261747246P 2012-12-29 2012-12-29
EP13756743.4A EP2880168B1 (en) 2012-08-05 2013-08-05 Inducible coexpression system

Publications (1)

Publication Number Publication Date
DK3187586T3 true DK3187586T3 (da) 2019-10-14

Family

ID=49111529

Family Applications (2)

Application Number Title Priority Date Filing Date
DK16201998.8T DK3187586T3 (da) 2012-08-05 2013-08-05 Inducerbar co-ekspressionssystem
DK13756743.4T DK2880168T3 (en) 2012-08-05 2013-08-05 INDUCERABLE CO EXPRESSION SYSTEM

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK13756743.4T DK2880168T3 (en) 2012-08-05 2013-08-05 INDUCERABLE CO EXPRESSION SYSTEM

Country Status (11)

Country Link
US (8) US9617335B2 (https=)
EP (4) EP2880168B1 (https=)
JP (3) JP6457387B2 (https=)
CN (2) CN111748510B (https=)
AU (3) AU2013299910B2 (https=)
CA (1) CA2880285C (https=)
DK (2) DK3187586T3 (https=)
ES (3) ES2954516T3 (https=)
IL (3) IL236975B (https=)
PL (1) PL3591057T3 (https=)
WO (1) WO2014025663A1 (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014029417B1 (pt) * 2012-05-25 2023-03-07 Cellectis Método ex vivo para a preparação de células t para imunoterapia
US20150353940A1 (en) * 2013-08-05 2015-12-10 Absci, Llc Vectors for use in an inducible coexpression system
US12157766B2 (en) * 2012-08-05 2024-12-03 Absci Corporation Cytoplasmic expression system
US11077144B2 (en) 2013-05-13 2021-08-03 Cellectis CD19 specific chimeric antigen receptor and uses thereof
JP6788255B2 (ja) * 2015-11-19 2020-11-25 国立大学法人信州大学 新規ベクター及びこれを用いた可溶化タンパク質の製造方法
SG11201811478TA (en) * 2016-01-12 2019-01-30 Intron Biotechnology Inc Freeze-dried formulations of antibacterial protein
CN106190940B (zh) * 2016-07-19 2019-06-14 北京三元基因药业股份有限公司 表达抗TNF抗体Fab片段的重组大肠杆菌工程菌
KR102480965B1 (ko) 2016-09-13 2022-12-26 알레간 인코포레이티드 안정화된 비단백질 클로스트리듐 독소 조성물
WO2019175881A1 (en) * 2018-03-14 2019-09-19 Technion Research & Development Foundation Limited A prognostic biomarker in cancer
JP7174990B2 (ja) * 2018-07-23 2022-11-18 国立大学法人山口大学 原核生物用発現ベクター
WO2020069011A1 (en) 2018-09-25 2020-04-02 Absci, Llc Protein purification methods
ES2944837T3 (es) 2018-11-08 2023-06-26 Sutro Biopharma Inc Cepas de E. coli con citoplasma oxidativo
CN109371049A (zh) * 2018-11-14 2019-02-22 天津大学 分子伴侣在促进单克隆抗体的形成和/或提高单克隆抗体的表达量中的应用
CN111269294B (zh) * 2018-12-05 2023-03-28 广州中国科学院先进技术研究所 纤维寡糖转运蛋白LacY的突变位点、突变转运蛋白LacY及其制备方法和应用
EP3935154A1 (en) * 2019-04-04 2022-01-12 Braskem S.A. Metabolic engineering for simultaneous consumption of xylose and glucose for production of chemicals from second generation sugars
CN110616181A (zh) * 2019-09-27 2019-12-27 北京理工大学 一株基于大肠杆菌改造的工程菌株
CN112980891B (zh) * 2019-12-16 2023-12-12 中国科学院分子植物科学卓越创新中心 一种基于CRISPR-Cas的大肠杆菌基因组编辑工具
US12351850B2 (en) 2020-04-30 2025-07-08 Sutro Biopharma, Inc. Methods of producing full-length antibodies using E. coli
BE1029145B1 (fr) * 2021-02-26 2022-09-27 Curavac Europe Methode de production d'une forme periplasmique de la proteine crm197
CN113122552B (zh) * 2021-04-21 2022-07-26 西北农林科技大学 黄瓜谷氧还蛋白基因CsGRX4及其灰霉菌感病性的应用
JP2024533596A (ja) 2021-09-17 2024-09-12 アブサイ コーポレイション トランスファーｒｎａの組成、及び非標準アミノ酸を含むタンパク質の生産における使用
US20250383346A1 (en) * 2022-06-29 2025-12-18 Absci Corporation Affinity screening method
WO2024040020A1 (en) 2022-08-15 2024-02-22 Absci Corporation Quantitative affinity activity specific cell enrichment
CN120731217A (zh) 2022-12-21 2025-09-30 唐纳德丹福斯植物科学中心 抗微生物肽及其修饰
CN116875524B (zh) * 2023-09-08 2024-03-26 清华大学 一种在微生物中调控多基因表达的方法及其应用
WO2025058962A1 (en) 2023-09-11 2025-03-20 Absci Corporation High-throughput methods for kinetic characterization, quantifying and optimizing antibodies and antibody fragments expression in bacteria
US20250109209A1 (en) 2023-10-03 2025-04-03 Absci Corporation Tl1a associated antibody compositions and methods of use
WO2025122885A1 (en) 2023-12-08 2025-06-12 Absci Corporation Anti-her2 associated antibody compositions designed by artificial intelligence and methods of use
WO2025144700A1 (en) 2023-12-27 2025-07-03 Absci Corporation Nanobody library screening using bacterial surface display
CN118064437B (zh) * 2024-04-24 2024-09-10 山东福洋生物科技股份有限公司 一种多启动子结构元件及其构建方法和应用
WO2025259864A1 (en) 2024-06-12 2025-12-18 Absci Corporation Expression of proteins containing non-standard amino acids
CN119410683B (zh) * 2025-01-08 2025-05-23 北京化工大学 一种生物发酵-全细胞催化级联生产己二酸的方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2660397A (en) * 1996-04-05 1997-10-29 Board Of Regents, The University Of Texas System Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells
US6083715A (en) 1997-06-09 2000-07-04 Board Of Regents, The University Of Texas System Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells
CN1064052C (zh) 1997-09-29 2001-04-04 中国科学院微生物研究所 甲状旁腺素相关蛋白人源化抗体及其制备方法
US6872563B1 (en) * 1999-10-05 2005-03-29 President And Fellows Of Harvard College Compositions and methods for production of disulfide bond containing proteins in host cells
AU2001249265B2 (en) 2000-03-24 2006-10-26 Xoma Technology Ltd. Methods and cells for expression of recombinant protein products
US6979556B2 (en) * 2000-12-14 2005-12-27 Genentech, Inc. Separate-cistron contructs for secretion of aglycosylated antibodies from prokaryotes
CN100513414C (zh) * 2001-08-27 2009-07-15 杰南技术公司 进行抗体表达和装配的系统
ATE534669T1 (de) * 2002-05-28 2011-12-15 Omrix Biopharmaceuticals Inc Verfahren zum erhalten von anti-idiotyp antikörpern
EP1539794B1 (en) * 2002-07-03 2008-12-31 Dow Global Technologies Inc. Benzoate- and anthranilate-inducible promoters
PT1570060E (pt) * 2002-12-02 2007-09-13 Basf Ag ''sistema de expressão indutível de l-ramnose''
JP5176114B2 (ja) * 2005-06-06 2013-04-03 フェネックス インコーポレイテッド 細菌宿主細胞におけるマンニトール誘導のプロモーター系
US7351563B2 (en) 2005-06-10 2008-04-01 The Board Of Trustees Of The Leland Stanford Junior University Cell-free extracts and synthesis of active hydrogenase
US8178338B2 (en) 2005-07-01 2012-05-15 The Regents Of The University Of California Inducible expression vectors and methods of use thereof
JP4270466B2 (ja) * 2005-09-02 2009-06-03 国立大学法人福井大学 ＮＡＤａｓｅ、ＳＮＩおよびＳＬＯ遺伝子を含むオペロンから発現するタンパク質の製造方法、それにより得られるタンパク質およびその使用
US7816117B2 (en) 2006-04-26 2010-10-19 President And Fellows Of Harvard College Prokaryotic host cells for expressing proteins rich in disulfide bonds
EP2155868A2 (en) * 2007-04-19 2010-02-24 Codon Devices, Inc Engineered nucleases and their uses for nucleic acid assembly
EP2155789B1 (en) 2007-05-01 2013-07-24 Research Development Foundation Immunoglobulin fc libraries
CN107119095B (zh) 2008-01-03 2022-07-05 康乃尔研究基金会有限公司 原核生物中的糖基化蛋白表达
FI20095615A0 (fi) * 2009-06-02 2009-06-02 Oulun Yliopisto Menetelmä luonnollisesti laskostuneiden proteiinien tuottamiseksi prokaryootti-isännässä
WO2011116184A2 (en) * 2010-03-17 2011-09-22 Cornell University Methods and compositions for targeted mutagenesis in bacteria
EP2386641A1 (en) * 2010-05-11 2011-11-16 Université Catholique De Louvain Method for extracellular production of recombinant biomolecules in a microorganism
FI20115115A0 (fi) 2011-02-04 2011-02-04 Oulun Yliopisto Menetelmä disulfidisidoksia sisältävien proteiinien tuottamiseksi prokaryoottisytoplasmassa

Also Published As

Publication number Publication date
EP3591057A1 (en) 2020-01-08
US9617335B2 (en) 2017-04-11
JP2015524281A (ja) 2015-08-24
EP3187586A1 (en) 2017-07-05
IL236975B (en) 2019-06-30
US20200063116A1 (en) 2020-02-27
IL264384B (en) 2020-08-31
JP2022068332A (ja) 2022-05-09
DK2880168T3 (en) 2017-04-18
US20200172915A1 (en) 2020-06-04
US20170159061A1 (en) 2017-06-08
US10465197B2 (en) 2019-11-05
US20200032276A1 (en) 2020-01-30
EP3591057B1 (en) 2023-06-07
IL236975A0 (en) 2015-03-31
CN111748510B (zh) 2023-08-15
AU2019202844A1 (en) 2019-05-16
JP2019068830A (ja) 2019-05-09
CN111748510A (zh) 2020-10-09
ES2621320T3 (es) 2017-07-03
JP6457387B2 (ja) 2019-01-23
CN104603274B (zh) 2020-08-18
EP3591057B9 (en) 2023-07-19
ES2750005T3 (es) 2020-03-24
IL276141B (en) 2022-03-01
EP3187586B1 (en) 2019-09-25
CA2880285C (en) 2022-11-01
PL3591057T3 (pl) 2023-10-02
US10604761B2 (en) 2020-03-31
EP3591057C0 (en) 2023-06-07
HK1210804A1 (en) 2016-05-06
IL264384A (en) 2019-02-28
EP4273257A2 (en) 2023-11-08
IL276141A (en) 2020-09-30
JP7032292B2 (ja) 2022-03-08
CN104603274A (zh) 2015-05-06
ES2954516T3 (es) 2023-11-22
AU2013299910B2 (en) 2019-01-24
US20230340501A1 (en) 2023-10-26
EP2880168B1 (en) 2017-01-11
EP2880168A1 (en) 2015-06-10
AU2022204192A1 (en) 2022-07-07
US11447781B2 (en) 2022-09-20
WO2014025663A1 (en) 2014-02-13
AU2019202844B2 (en) 2022-03-17
US20160152701A1 (en) 2016-06-02
US20150225731A1 (en) 2015-08-13
US11214807B2 (en) 2022-01-04
AU2013299910A1 (en) 2015-03-12
CA2880285A1 (en) 2014-02-13
US20220090093A1 (en) 2022-03-24
EP4273257A3 (en) 2024-02-28

Similar Documents

Publication Publication Date Title
FIC20240017I1 (fi) Rotsanoliksitsumabi
FIC20230011I1 (fi) Farisimabi
FIC20230015I1 (fi) Sutimlimabi
FIC20220016I1 (fi) Amivantamabi
DK3187586T3 (da) Inducerbar co-ekspressionssystem
EP2763896A4 (en) UNMANUFACTURED AIRCRAFT WITH SEVERAL ROTORS
DK2859055T3 (da) Polymercoatings
HUE045144T2 (hu) Véragygát-shuttle
EP2880683A4 (en) BVA INTERPOSER
DK2825087T3 (da) Otoscanner
EP2809145A4 (en) CHLOROPLAST TRANSIT PEPTIDES
DK2839013T3 (da) Ikke-disruptiv-gen-targetering
EP2814472A4 (en) DITHIOAMINE REDUCING AGENTS
DK2873977T3 (da) Dobbeltdækker-rørdispenser
DE112012006109A5 (de) Okklusionsschienenanordnung
DK2854722T3 (da) Stomipose
EP2941099A4 (en) SWITCHING DEVICE
EP2831482A4 (en) Flange gasket
EP2816694A4 (en) FLAT CABLE WINDING DEVICE
DK2825157T3 (da) Aminosyrelipider
EP2809729A4 (en) Siloxane polyether copolymers
EP2862179A4 (en) FUEL CURRENT INSPECTION PROBE
EP2869113A4 (en) DISPLAY DEVICE FOR VEHICLE
FR2991688B1 (fr) Biosolubilisant
DE112012006214T8 (de) Wulstringwickler